Search results
Forbes Daily: Election Gambling Faces An Uncertain Future
Forbes· 1 day agoEarlier this year, my husband and I traveled to Japan, and we enjoyed how far the U.S. dollar took us—especially when dining on sushi and ramen. In March, the number of visitors to Japan exceeded ...
Earnings call: IAC and Angi Inc. display optimism despite challenges By Investing.com
Investing.com· 7 days agoThe announcement included a partnership with OpenAI, a welcoming of new Angi Inc. CEO Jeff Kipp, and...
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoPhathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2024 Earnings Call Transcript May 11, 2024 Phathom...
7 F-Rated Stock Picks to Avoid Like the Plague in May
InvestorPlace· 6 days agoThe stock market is off to a washing machine kind of start for 2024, with gains and lulls that keep...
Many U.S. state pensions have funds tangled up in ByteDance. It’s impossible to know how much
Fortune· 7 days agoAfter all, behind the $9.5 billion of venture capital that has been poured into ByteDance since 2012 is a sprawling list of U.S. pension funds (and yes, the endowments, nonprofits, insurance ...
Colossus SSP Files Lawsuit Against Adalytics For Defamation, Injurious Falsehood and False...
WTNH-TV New Haven· 2 days agoColossus Media LLC ("Colossus SSP" or the "Company"), the inclusive supply-side advertising platform, today filed a civil lawsuit against Adalytics Research LLC of New York City for defamation ...
Earnings call: Seres Therapeutics reports on Q1 2024 with VOWST updates By Investing.com
Investing.com· 3 days agoSeres Therapeutics (NASDAQ:MCRB), a biotechnology firm focused on microbiome therapeutics, has...
Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
Casper Star-Tribune· 5 days agoInhibrx, Inc. (Nasdaq: INBX) ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its ...